AIImpactLab
9 impact clustersWork & marketsCognition & learningTechnical failuresPrivacySecurityEnvironmentLaw & informationSocial good & healthSystemic risk
Search the evidence

Find the signal.

Search titles, impact clusters, countries, organizations and the full text of every analysis.

9 stories found

A grocery shopper faces variable price labels beside a biomedical researcher reviewing abstract dataset screens.
Work & marketsGlobal+3 clusters01

AI can change your price and speed science. Who gets the gain?

The same word, efficiency, can hide two very different experiences. CBS examines the prospect of AI-enabled individualized pricing: a retailer can learn what different shoppers may be willing to pay while the shopper loses a stable point of comparison. It cites a 2025 Instacart experiment. Consumer Reports' corrected finding is a maximum 23% price difference for a single item in its synchronized tests, not for an entire basket; CBS's basket wording should not be repeated as fact. Instacart says the test did not use personal characteristics to set prices, disputes the annualized family-cost estimate, and ended the item-price experiment in December 2025. Walmart also denies using personal data to set individualized prices; patent filings alone do not establish deployed practice. In a separate peer-reviewed Scientific Data study, researchers used four language models to screen biomedical datasets across three repositories and disease settings. They report a median screening time of six minutes, with the best individual models reaching held-out sensitivity around 88% to 93% and specificity varying from 85.1% to 99.1%. Ensemble decisions reached 100% sensitivity in the evaluated settings, not a general guarantee. These are separate technologies and evidence streams, not one causal story. Put together, they make a sharper question: when AI cuts friction, does the benefit reach the person whose life is affected? A shopper needs transparent, comparable prices; a scientist needs auditable false negatives and human review. Speed alone cannot answer either question.

7 min
A young adult holds a phone displaying a private health question while a subtle anxiety waveform becomes a bridge toward a warmly lit human support doorway.
Social good & healthUnited States+3 clusters02

AI health questions may be a distress signal, not a cause

The most important finding in this study is also the easiest one to misuse. Researchers analyzed a nationally representative sample of 96,205 U.S. college students and found that those who used generative AI for health questions had 52% higher adjusted odds of screening positive for clinically significant anxiety and 46% higher adjusted odds of screening positive for depression. The University of Florida translates the raw comparison more plainly: about 52% of AI health users screened positive for anxiety versus 43% of nonusers, while 47% screened positive for depression versus 38%. Those numbers do not show that chatbots caused distress. The data were cross-sectional, the direction of the relationship is unknown, and students who are already worried, isolated, unable to access care, or seeking repeated reassurance may be more likely to ask AI for help. The association remained after controlling for prior diagnoses, which makes it useful as a marker but not a verdict. The humane response is neither to panic about chatbots nor to treat their users as patients. Health-oriented AI services can offer a private doorway to information, but they should recognize repeated distress patterns, make uncertainty visible, avoid reinforcing rumination, and provide clear routes to qualified human support. The product insight is personal: sometimes the question tells us more than the answer.

10 min
A polished AI-generated medical note floats over a patient conversation while missing clinical facts glow in the gaps.
Social good & healthUnited Kingdom and international healthcare+4 clusters03

AI scribes save clinicians time while hiding errors inside fluent notes

Ambient AI scribes are spreading faster than the evidence needed to govern them. A new British Dental Journal literature review searched research published from January 2015 through December 2025, screened 3,036 records, and included 57 studies. Only three focused on dentistry. The systems can reduce documentation burden and may improve burnout measures, but fluent notes can conceal omissions, substitutions, and hallucinations that are harder to notice precisely because the prose reads well. In one dental speech-recognition study, an experimental system reached a 3.7 percent word-error rate and the strongest commercial product reached 5.4 percent, yet clinically meaningful mistakes remained, including changing “16 hours” to “10 minutes.” Across wider healthcare research cited by the review, one analysis found hallucinations in 1.47 percent of note sentences and omissions corresponding to 3.45 percent of transcript sentences. Those figures are not universal error rates; studies used different systems, specialties, and definitions. The severity evidence is still sobering: 44 percent of hallucinated sentences and 16.7 percent of omissions in that study were classified as capable of major harm. Human review reduced clinically significant errors from 63.6 percent to 7.8 percent in another cited study, but that shifts clinicians from writers to editors and potential liability sinks. Patient attitudes also depend on disclosure. Favorability toward ambient documentation fell when people received fuller information about how it works. The technology may genuinely return attention to the patient. Its success will depend on whether saved typing time becomes careful verification time rather than disappearing from the workflow.

11 min
An ordinary chest CT reveals a small illuminated esophageal lesion while an AI triage path directs the patient toward confirmatory endoscopy.
Social good & healthChina and international validation sites+4 clusters04

AI found hidden esophageal cancers in CT scans patients already had

A multicenter Nature Medicine study reports that an AI system called EAGLE can identify esophageal cancer and precancerous lesions in noncontrast chest CT scans that were not acquired specifically for the esophagus. The model was trained on 6,813 patients and validated across 12 centers in three countries involving 80,612 patients. In external cohorts totaling 11,466 people, it reached 90.0 percent sensitivity for cancer and 98.5 percent specificity, while sensitivity for precancerous lesions was lower at 52.5 percent. A calibration cohort of 35,402 patients reduced false positives by 72.7 percent while preserving sensitivity. In a prospective hospital cohort of 17,446 patients, 38 of 90 positive predictions were true positives, producing a 42.2 percent positive predictive value and 87.8 percent sensitivity for cancer. A real-world low-dose screening cohort of 10,959 people reported 99.94 percent specificity. The opportunity is unusually practical: use scans already being performed to identify people who should receive confirmatory endoscopy. But the strongest efficiency claims remain modeled. Simulations suggested triage could triple detection, reduce diagnostic time by 70.4 percent, and lower costs in seven of eight countries. Those are not randomized outcomes or evidence of reduced mortality. Most data came from China, follow-up was under two years, endoscopy adherence was limited, and broader validation is needed for different disease patterns. EAGLE may make existing imaging more valuable. It has not yet proved that population deployment improves survival or avoids harmful overdiagnosis.

10 min
A sterile robotic wet lab connects an AI experiment planner to pipettes and culture plates while a scientist holds a physical safety interlock over one amber anomaly.
Social good & healthUnited States+4 clusters05

Anthropic builds a wet lab as it explores AI-directed biology

Anthropic has confirmed that it is establishing a wet laboratory in the San Francisco Bay Area and exploring whether Claude can direct robotic equipment with limited human intervention. The company's life-sciences leadership told Reuters that biology ultimately requires experiments in the physical world and that human oversight remains essential. Anthropic says the laboratory is not specifically a drug-discovery facility, has not disclosed its exact work, and is not running clinical trials. Its broader ambitions include tools for rare, neglected, and currently difficult-to-treat conditions, while its Model Hardware Standard is intended to help AI systems communicate with laboratory equipment. The company also acquired Coefficient Bio; Reuters reported a roughly $400 million stock price based on a source, but Anthropic confirmed the acquisition without confirming the amount. The opportunity is substantial: an AI system that can design an experiment, interpret results, and revise the next run could compress research cycles. The risk also changes when text output becomes physical action. A hallucinated protocol, contaminated sample, unsafe reagent combination, or overconfident biological inference can propagate through automation before a person notices. Governance should therefore attach to the closed loop, not only the model. Every AI-directed experiment needs bounded hardware permissions, validated protocols, chain-of-custody logs, biological screening, anomaly detection, and a human stop authority that remains effective when the system proposes the next step faster than a scientist can review it.

8 min
A conventional microscope with a compact motorized stage scans a bone-marrow slide and routes candidate-cell evidence to a gloved clinical reviewer.
Social good & healthUnited States and Global+3 clusters06

A low-cost self-driving microscope screens bone marrow slides for acute leukemia

A Nature Communications study presents ALLocate, a low-cost AI-powered plugin that turns a conventional microscope into a self-driving screening system for acute leukemia. The system automatically selects useful bone-marrow regions, detects cells, and produces a slide-level result without a whole-slide scanner. Researchers trained and evaluated it with more than 11,000 annotated regions and 130,000 annotated cells, then used independent multi-institutional cohorts that included 165 physical bone-marrow smear slides. Reported performance exceeded 0.99 AUROC for region selection, reached 0.90 mean average precision for cell detection, and achieved 88 percent accuracy for diagnosis on glass slides. That combination could make automated screening more accessible where scanners and specialist expertise are scarce. It does not support an autonomous final diagnosis. An 88 percent result leaves clinically important errors, and the study does not erase the need for population-specific validation, slide-quality checks, calibration, human confirmation, and escalation to a pathologist. The strongest deployment is a lower-cost bridge to expertise, not a substitute for it.

5 min
Several luminous designed protein binders attach to a transparent molecular target above a physical laboratory assay tray.
Social good & healthGlobal+4 clusters07

Claude designs protein binders that survive wet-lab testing

Anthropic reports that Claude Opus 4.8 and Mythos Preview designed protein binders against 15 targets and succeeded against 14 after external laboratories produced and tested the designs. Reported hit rates ranged from 22.6 percent to 35.1 percent depending on the setup, above the 10 to 15 percent that Anthropic says is typical in current campaigns. The models orchestrated existing protein-design and folding tools with minimal human scientific guidance, producing 354 confirmed binders from 1,320 designs. This is a meaningful result because physical testing separates a scientific claim from a plausible-looking output. It is not a finished drug. Minibinders are an early design step, one target failed, additional characterization is planned, and the campaigns used substantial compute and specialist infrastructure. The same autonomy is dual-use, so Anthropic says its strongest biological capabilities remain restricted while it develops scientist access. The breakthrough and the control problem arrive together.

7 min
A strand of artificial intelligence code becomes a bacteriophage above a laboratory petri dish, marking the transition from digital design to living replication.
Social good & healthUnited States+4 clusters08

Scientists used AI to design viable viruses. The safety boundary just crossed into biology

Scientists used genome language models to design 16 viable bacteriophages that infected and killed the bacterium E coli in laboratory tests. The New York Times reports the peer-reviewed publication of work in which researchers generated thousands of candidate genomes, synthesized 285 designs, and identified 16 functional phages. These are viruses that target bacteria, not humans; Arc Institute says the models excluded eukaryotic viruses from training and the working phages showed restricted host range in testing. The result is both a therapeutic opportunity and a dual-use warning. AI-assisted phage design could help attack antibiotic-resistant bacteria, but it also proves that generative output can become a replicating biological system once synthesis and experimentation enter the chain.

5 min
A warped molecular structure resolving into a physically constrained chemical lattice.
Work & marketsGlobal+3 clusters09

Liu et al., “Integrating chemical priors and physical laws to mitigate hallucinations in structure-based drug design”

The NUS/Harbin-led team identifies a domain-specific form of generative-AI hallucination: molecular candidates can receive strong predicted binding scores while violating basic chemistry or producing physically impossible atomic arrangements. Its DrugRPG framework incorporates chemical-foundation-model priors and differentiable physical constraints during molecule generation, reducing severe steric clashes by 65.4% relative to the reported state-of-the-art baseline and increasing by 28.6% the share of generated candidates meeting combined potency, stability, and synthetic-feasibility criteria.

2 min